Skye Bioscience, Inc.·4

Jan 9, 10:30 AM ET

Rai Sukhwinder Singh 4

4 · Skye Bioscience, Inc. · Filed Jan 9, 2023

Insider Transaction Report

Form 4
Period: 2023-01-05
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-05$0.02/sh+250,000$4,250250,000 total
    Exercise: $0.02Exp: 2033-01-05Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 and the options will vest in equal monthly installments over the one year period beginning November 10, 2022.

Documents

1 file
  • 4
    wf-form4_167327820816124.xmlPrimary

    FORM 4